Hyperfine (HYPR) EBIT Margin (2021 - 2026)

Hyperfine (HYPR) posted EBIT Margin of 219.27% for Q1 2026, down 51.35% on a QoQ basis from 144.87% in Q4 2025, and up 29089.0% year-over-year from N/an in Q1 2025.

Hyperfine (HYPR) EBIT Margin (2021 - 2026) Analysis & Trends

Hyperfine's EBIT Margin history runs 6 years deep, the most recent figure standing at 219.27% for Q1 2026.

  • Quarterly EBIT Margin rose 29089.0% year-over-year to 219.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 226.64% (up 14394.0% YoY) and the FY2025 annual result came in at 273.43%, up 6190.0% from the prior year.
  • EBIT Margin was 219.27% for Q1 2026 at Hyperfine, down from 144.87% in the prior quarter.
  • Across five years, EBIT Margin topped out at 144.87% in Q4 2025 and bottomed at 1575.28% in Q1 2022.
  • A 5-year average of 545.02% and a median of 432.95% in 2023 frame the typical range for EBIT Margin.
  • Annual changes were most pronounced in 2022 — EBIT Margin surged 502616 bps — and 2025, when it tumbled 18694 bps.
  • Hyperfine's EBIT Margin stood at 957.09% in 2022, then jumped by 55 bps to 432.95% in 2023, then fell by 7 bps to 463.81% in 2024, then soared by 69 bps to 144.87% in 2025, then sank by 51 bps to 219.27% in 2026.
  • Business Quant data shows HYPR's EBIT Margin at 219.27% in Q1 2026, 144.87% in Q4 2025, and 259.53% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.05%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 15.55%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 19.10%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 28.97%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 21.42%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 6.17%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.04%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Hyperfine 92.81 Mn 51.53 Mn 1.98 Mn -219.27%

Historic Data

Download Data
DateValue
Mar 31, 2026 -219.27%
Dec 31, 2025 -144.87%
Sep 30, 2025 -259.53%
Jun 30, 2025 -355.90%
Mar 31, 2025 -510.15%
Dec 31, 2024 -463.81%
Sep 30, 2024 -300.93%
Jun 30, 2024 -298.71%
Mar 31, 2024 -323.22%
Dec 31, 2023 -432.95%
Sep 30, 2023 -504.68%
Jun 30, 2023 -345.81%
Mar 31, 2023 -494.69%
Dec 31, 2022 -957.09%
Sep 30, 2022 -565.67%
Jun 30, 2022 -1,512.85%
Mar 31, 2022 -1,575.28%
Dec 31, 2021 -5,983.26%
Sep 30, 2021 -4,417.79%
Jun 30, 2021 -4,074.30%